| |||||||
ShanghaiTech University Knowledge Management System
Multiple Signaling Roles of CD3 epsilon and Its Application in CAR-T Cell Therapy | |
2020-08-20 | |
发表期刊 | CELL (IF:45.5[JCR-2023],49.0[5-Year]) |
ISSN | 0092-8674 |
EISSN | 1097-4172 |
卷号 | 182期号:4页码:855-+ |
发表状态 | 已发表 |
DOI | 10.1016/j.cell.2020.07.018 |
摘要 | A T cell receptor (TCR) mediates antigen-induced signaling through its associated CD3 epsilon, delta, gamma, and zeta, but the contributions of different CD3 chains remain elusive. Using quantitative mass spectrometry, we simultaneously quantitated the phosphorylation of the immunoreceptor tyrosine-based activation motif (ITAM) of all CD3 chains upon TCR stimulation. A subpopulation of CD3 epsilon ITAMs was mono-phosphorylated, owing to Lck kinase selectivity, and specifically recruited the inhibitory Csk kinase to attenuate TCR signaling, suggesting that TCR is a self-restrained signaling machinery containing both activating and inhibitory motifs. Moreover, we found that incorporation of the CD3 epsilon cytoplasmic domain into a second-generation chimeric antigen receptor (CAR) improved antitumor activity of CAR-T cells. Mechanistically, the Csk-recruiting ITAM of CD3 epsilon reduced CAR-T cytokine production whereas the basic residue rich sequence (BRS) of CD3 epsilon promoted CAR-T persistence via p85 recruitment, Collectively, CD3 epsilon is a built-in multifunctional signal tuner, and increasing CD3 diversity represents a strategy to design next-generation CAR. |
收录类别 | SCI ; SCIE |
语种 | 英语 |
资助项目 | Chinese Academy of Sciences (CAS)[XDB29000000][QYZDB-SSW-SMC048] ; National Natural Science Foundation of China (NSFC)[31530022][31861133009][31621003] ; National Key R&D Program of China[2019YFA0111001][2018YFA0800702] ; Double First-Class University grants of China[BMU2017YJ003][BMU2018XTZ002] ; NSFC[31670919][31670751] |
WOS研究方向 | Biochemistry & Molecular Biology ; Cell Biology |
WOS类目 | Biochemistry & Molecular Biology ; Cell Biology |
WOS记录号 | WOS:000561488500009 |
出版者 | CELL PRESS |
WOS关键词 | PROLINE-RICH SEQUENCE ; RECEPTOR ZETA ; TYROSINE PHOSPHORYLATION ; ABSOLUTE QUANTIFICATION ; MEMBRANE ASSOCIATION ; ACTIVATION MOTIFS ; SUBUNIT CONTAINS ; BINDING MOTIF ; KINASE CSK ; TCR-ZETA |
原始文献类型 | Article |
引用统计 | 正在获取...
|
文献类型 | 期刊论文 |
条目标识符 | https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/123078 |
专题 | 生命科学与技术学院_PI研究组_王皞鹏组 |
通讯作者 | Hui, Enfu; Wong, Catherine Chiulan; Xu, Chenqi |
作者单位 | 1.Univ Chinese Acad Sci, Chinese Acad Sci, Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol,Shanghai Inst Biochem & Ce, Shanghai 200031, Peoples R China 2.Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA 3.Peking Univ, Hlth Sci Ctr, Hosp 1, Ctr Precis Med Multiom Res, Beijing 100191, Peoples R China 4.Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China 5.Zhejiang Univ, Sch Med, Dept Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China 6.Zhejiang Univ, Inst Hematol, Hangzhou 310058, Zhejiang, Peoples R China 7.Lab Stem Cell & Immunotherapy Engn, Hangzhou 310058, Zhejiang, Peoples R China 8.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China 9.Peking Univ, Sch Basic Med Sci, Hlth Sci Ctr, Beijing 100191, Peoples R China 10.Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China 11.Univ Chinese Acad Sci, Sch Life Sci, Hangzhou Inst Adv Study, Hangzhou 310024, Zhejiang, Peoples R China 12.Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA 13.Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA |
推荐引用方式 GB/T 7714 | Wu, Wei,Zhou, Qiuping,Masubuchi, Takeya,et al. Multiple Signaling Roles of CD3 epsilon and Its Application in CAR-T Cell Therapy[J]. CELL,2020,182(4):855-+. |
APA | Wu, Wei.,Zhou, Qiuping.,Masubuchi, Takeya.,Shi, Xiaoshan.,Li, Hua.,...&Xu, Chenqi.(2020).Multiple Signaling Roles of CD3 epsilon and Its Application in CAR-T Cell Therapy.CELL,182(4),855-+. |
MLA | Wu, Wei,et al."Multiple Signaling Roles of CD3 epsilon and Its Application in CAR-T Cell Therapy".CELL 182.4(2020):855-+. |
条目包含的文件 | ||||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 |
修改评论
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。